Indications for radiotherapy after neck dissection

Head and Neck

Volumn 34, Issue 1, 2012, Pages 113-119

  Strojan, Primož ^a   Ferlito, Alfio ^b   Langendijk, Johannes A ^c   Silver, Carl E ^d  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

head and neck; neck dissection; postoperative radiotherapy; regional control; squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM;

ADJUVANT THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CERVICAL LYMPH NODE; CLINICAL EFFECTIVENESS; DISEASE FREE SURVIVAL; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MOUTH CAVITY; NECK DISSECTION; OVERALL SURVIVAL; POSTOPERATIVE CARE; POSTOPERATIVE RADIOTHERAPY; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; TREATMENT INDICATION; TUMOR VOLUME;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NECK; NECK DISSECTION; NEOPLASM STAGING;

EID: 83455214079     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21599     Document Type: Article

References (56)

1. Langendijk JA, Ferlito A, Takes RP, et al. Postoperative strategies after primary surgery for squamous cell carcinoma of the head and neck. Oral Oncol 2010; 48: 577-585.
2. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350: 1945-1952. (Pubitemid 38580197)
3. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004; 350: 1937-1944.
4. Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (22931) and RTOG (9501). Head Neck 2005; 27: 843-850. (Pubitemid 41395696)
5. Jose J, Ferlito A, Rodrigo JP, Devaney KO, Rinaldo A, MacLennan K,. Soft tissue deposits from head and neck cancer: an under-recognised prognostic factor? J Laryngol Otol 2007; 121: 1115-1117 (editorial). (Pubitemid 351650713)
6. Amdur RJ, Parsons JT, Mendenhall WM, Million RR, Stringer SP, Cassisi NJ,. Postoperative irradiation for squamous cell carcinoma of the head and neck: an analysis of treatment results and complications. Int J Radiat Oncol Biol Phys 1989; 16: 25-36. (Pubitemid 19045331)
7. Cooper JS, Pajak TF, Forastiere A, et al. Precisely defining high-risk operable head and neck tumors based on RTOG #85-03 and #88-24: targets for postoperative radiochemotherapy? Head Neck 1998; 20: 588-594. (Pubitemid 28405799)
8. Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 51: 571-578.
9. Rosenthal DI, Liu L, Lee JH, et al. Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck. Head Neck 2002; 24: 115-126. (Pubitemid 34111508)
10. Langendijk JA, de Jong MA, Leemans CR, et al. Postoperative radiotherapy in squamous cell carcinoma of the oral cavity: the importance of the overall treatment time. Int J Radiat Oncol Biol Phys 2003; 57: 693-700. (Pubitemid 37194295)
11. Langendijk JA, Slotman BJ, van der Waal I, Doornaert P, Berkof J, Leemans CR,. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Cancer 2005; 104: 1408-1417. (Pubitemid 41356156)
12. Jonkman A, Kaanders JH, Terhaard CH, et al. Multicenter validation of recursive partitioning analysis classification for patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 2007; 68: 119-125. (Pubitemid 46589828)
13. Leõn X, Lõpez M, Piñeiro Z, Langendijk JA, Leemans CR, Quer M,. External validation of a risk group defined by recursive partitioning analysis in patients with head and neck carcinoma treated with surgery and postoperative radiotherapy. Head Neck 2007; 29: 815-821. (Pubitemid 350303668)
14. Shaw RJ, Lowe D, Woolgar JA, et al. Extracapsular spread in oral squamous cell carcinoma. Head Neck 2010; 32: 714-722.
15. Peters LJ, Goepfert H, Ang KK, et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 1992; 26: 3-11. (Pubitemid 23137882)
16. Snow GB, Annyas AA, van Slooten EA, Bartelink H, Hart AAM,. Prognostic factors of neck node metastasis. Clin Otolaryngol 1982; 7: 185-192. (Pubitemid 12088842)
17. DeSanto LW, Beahrs OH, Holt JJ, O'Fallon WM,. Neck dissection and combined therapy. Study of effectiveness. Arch Otolaryngol 1985; 111: 366-370. (Pubitemid 15233991)
18. O'Brien CJ, Soong SJ, Urist MM, Maddox AW,. Is modified radical neck dissection only a staging procedure? Cancer 1987; 59: 994-999. (Pubitemid 17024658)
19. Medina JE, Byers RM,. Supraomohyoid neck dissection: rationale, indication, and surgical technique. Head Neck 1989; 11: 111-122. (Pubitemid 20044977)
20. Traynor SJ, Cohen JI, Gray J, Andersen PE, Everts EC,. Selective neck dissection and the management of the node-positive neck. Am J Surg 1996; 172: 654-657. (Pubitemid 27024772)
21. Barzan L, Talamini R,. Analysis of prognostic factors for recurrence after neck dissection. Arch Otolaryngol Head Neck Surg 1996; 122: 1299-1302. (Pubitemid 26408909)
22. Wolfensberger M, Zbaeren P, Dulguerov P, Müller W, Arnoux A, Schmid S,. Surgical treatment of early oral carcinoma: results of a prospective controlled multicenter study. Head Neck 2001; 22: 525-530. (Pubitemid 32565524)
23. Coster JR, Foote RL, Olsen KD, Jack SM, Schaid DJ, DeSanto LW,. Cervical nodal metastasis of squamous cell carcinoma of unknown origin: indications for withholding radiation therapy. Int J Radiat Oncol Biol Phys 1992; 23: 743-749.
24. Iganej S, Kagan R, Anderson P, et al. Metastatic squamous cell carcinoma of the neck from an unknown primary: management options and patterns of relapse. Head Neck 2002; 24: 236-246. (Pubitemid 34193248)
25. Patel RS, Clark J, Wyten R, Gao K, O'Brien CJ,. Squamous cell carcinoma from an unknown head and neck primary site: a "selective treatment" approach. Arch Otolaryngol Head Neck Surg 2007; 133: 1282-1287. (Pubitemid 350294260)
26. Gourin CG, Conger BT, Porubsyky ES, Sheils WC, Bilodeau PA, Coleman TA,. The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma. Laryngoscope 2008; 118: 1191-1194.
27. Hosal AS, Carrau RL, Johnson JT, Myers EN,. Selective neck dissection in the management of the clinically node-negative neck. Laryngoscope 2000; 110: 2037-2040.
28. Chepeha DB, Hoff PT, Taylor RJ, Bradford CR, Teknos TN, Esclamado RM,. Selective neck dissection for the treatment of neck metastasis from squamous cell carcinoma of the head and neck. Laryngoscope 2002; 112: 434-438. (Pubitemid 34225856)
29. Schmitz S, Machiels JP, Weynand B, Gregoire V, Hamoir M,. Results. of selective neck dissection in the primary management of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2009; 266: 437-443.
30. Olsen KD, Caruso M, Foote RL, et al. Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement. Arch Otolaryngol Head Neck Surg 1994; 120: 1370-1374. (Pubitemid 24378580)
31. Leemans CR, Tiwari R, van der Waal I, Karim ABMF, Nauta JJP, Snow GB,. The efficacy of comprehensive neck dissection with or without postoperative radiotherapy in nodal metastases of squamous cell carcinoma of the upper respiratory and digestive tract. Laryngoscope 1990; 100: 1194-1198.
32. Spiro RH, Morgan GJ, Strong EW, Shah JP,. Supraomohyoid neck dissection. Am J Surg 1996; 172: 650-653. (Pubitemid 27024771)
33. Byers RM, Clayman GL, McGill D, et al. Selective neck dissections for squamous cell carcinoma of the upper aerodigestive tract: patterns of regional failure. Head Neck 1999; 21: 499-505. (Pubitemid 29415153)
34. Brazilian Head and Neck Cancer Study Group. Results. of prospective trial on elective modified radical classical versus supraomohyoid neck dissection in the management of oral squamous cell carcinoma. Am J Surg 1998; 176: 422-427.
35. Kolli VR, Datta RV, Orner JB, Hicks WL, Loree TR,. The role of supraomohyoid neck dissection in patients with positive nodes. Arch Otolaryngol Head Neck Surg 2000; 126: 413-416. (Pubitemid 30140401)
36. Schiff BA, Roberts DB, El-Naggar A, Garden AS, Myers JN,. Selective vs modified neck dissection and postoperative radiotherapy vs observation in the treatment of squamous cell carcinoma of the oral tongue. Arch Otolaryngol Head Neck Surg 2005; 131: 874-878. (Pubitemid 41464478)
37. Ambrosch P, Kron M, Pradier O, Steiner W,. Efficacy of selective neck dissection: a review of 503 cases of elective and therapeutic treatment of the neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol Head Neck Surg 2001; 124: 180-187. (Pubitemid 32167807)
38. Jäckel MC, Ambrosch P, Christiansen H, Martin A, Steiner W,. Value of postoperative radiotherapy in patients with pathologic N1 neck disease. Head Neck 2008; 30: 875-882. (Pubitemid 352008947)
39. Chen TC, Wang CT, Ko JY, et al. Postoperative radiotherapy for primary early oral tongue cancer with pathologic N1 neck. Head Neck 2010; 32: 555-561.
40. Lavaf A, Genden EM, Cesaretti JA, Packer S, Kao J,. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma. Cancer 2008; 12: 535-543. (Pubitemid 351186195)
41. Kao J, Lavaf A, Teng MS, Huang D, Genden EM,. Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage. Int J Radiat Oncol Biol Phys 2008; 71: 362-370.
42. Shrime MG, Gullane PJ, Dawson L, et al. The impact of adjuvant radiotherapy on survival in T1-2N1 squamous cell carcinoma of the oral cavity. Arch Otolaryngol Head Neck Surg 2010; 136: 225-228.
43. Weiss MH, Harrison LB, Isaacs RS,. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head neck Surg 1994; 120: 699-702. (Pubitemid 24217580)
44. Pitman KT,. Rationale for elective neck dissection. Am J Otolaryngol 2000; 21: 31-37. (Pubitemid 30059062)
45. Pillsbury HC III, Clark M,. A rationale for therapy of the N0 neck. Laryngoscope 1997; 107: 1294-1315. (Pubitemid 27432904)
46. Lindberg R,. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tract. Cancer 1972; 29: 1446-1449.
47. Medina JE,. Management of the neck in squamous cell carcinoma of the head and neck. In:, Ensley JF, Gutkinf JS, Jacobs JR, Lippman SM, editors. Head and neck cancer. Amsterdam: Academic Press; 2003. pp 317-327.
48. Withers HR, Peters LJ, Taylor JMG,. Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys 1995; 31: 353-359.
49. Ferlito A, Rinaldo A, Silver CE, et al. Elective and therapeutic selective neck dissection. Oral Oncol 2006; 42: 14-25. (Pubitemid 41831517)
50. Vergeer MR, Doornaert PA, Jonkman A, et al. Ipsilateral irradiation for oral and oropharyngeal carcinoma treated with primary surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 2010 Feb 24. [Epub ahead of print].
51. Brazilian Head and Neck Cancer Study Group. End results of a prospective trial on elective lateral neck dissection vs. type III modified radical neck dissection in the management of supraglottic and transglottic carcinomas. Head Neck 1999; 21: 694-702.
52. Candela FC, Kothar K, Shah JP,. Patterns of cervical node metastases from squamous cell carcinoma of the oropharynx and hypopharynx. Head Neck 1990; 12: 197-203. (Pubitemid 20154998)
53. Davidson BJ, Kulkarny V, Delacure MD, Shah JP,. Posterior triangle metastases of squamous cell carcinoma of the upper aerodigestive tract. Am J Surg 1993; 166: 395-398. (Pubitemid 24240995)
54. Shah JP,. Pattern of cervical lymph node metastases form squamous carcinoma of the upper aerodigestive tract. Am J Surg 1990; 160: 405-409. (Pubitemid 20346332)
55. Byers RM, Weber RS, Andrews T, McGill D, Kare R, Wolf P,. Frequency and therapeutic implications of "skip metastases" in the neck from squamous cell carcinoma of the oral tongue. Head Neck 1997; 19: 14-19. (Pubitemid 26425084)
56. Moergel M, Jahn-Eimermacher A, Krummenauer F, et al. Effectiveness of adjuvant radiotherapy in patients with oropharyngeal and floor of the mouth squamous cell carcinoma and concomitant histologic verification of singular ipsilateral cervical lymph node metastasis (pN1-state): a prospective multicenter randomized controlled clinical trial using a comprehensive cohort design. Trials 2009; 10: 118 (abstract).